Kalanchoe laciniata
Kalanchoe laciniata · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Kalanchoe laciniata is a botanical species of significant interest due to its diverse array of bioactive secondary metabolites. Research focusing on the plant's leaves has identified key chemical constituents, including flavonoids, tannins, and sarmentosin. Studies evaluating aqua-methanolic and n-hexane extracts have demonstrated that these compounds possess notable biological properties. Specifically, the plant has exhibited significant cytotoxic and mutagenic activities during experimental assessments. Understanding these chemical profiles provides essential insights into the potential medicinal and toxicological implications of this species.
- Synonyms
- Cotyledon Laciniata · Kalanchoe Craibii · 8 more
- Common names
- Not available
- Family
- Crassulaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Kalanchoe laciniata is a versatile succulent known by a diverse array of regional names across the globe. In English-speaking regions, it is frequently referred to as the Christmastree plant. This botanical beauty is called Cuentas de oro in the Dominican Republic, reflecting its local cultural significance. In Russia, the species is recognized by the name Каланхоэ рассечённое. Finally, in Japan, this unique plant is identified by the name 伽藍菜.
Sources: Catalogue of Life (COL)
Synonyms
Kalanchoe laciniata is a plant known to be associated with several different botanical names within scientific literature. It is formally recognized as having the synonym Cotyledon laciniata, reflecting historical shifts in classification. Furthermore, this species shares names with Kalanchoe angustifolia and Kalanchoe carnea in various taxonomic records. The plant is also linked to the synonyms Kalanchoe craibii and Kalanchoe gloveri. Understanding these various relationships is essential for researchers tracking the botanical history of the species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Kalanchoe laciniata is a distinctive member of the kingdom Plantae. Within this vast biological kingdom, it is classified under the class Equisetopsida. This specific species belongs to the order Saxifragales, showcasing its unique evolutionary placement. It is further categorized within the family Crassulaceae, a group known for its diverse succulent traits. Ultimately, this plant is defined by its membership in the genus Kalanchoe.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Saxifragales |
| Family | Crassulaceae |
| Genus | Kalanchoe |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Kalanchoe laciniata is a distinctive plant species primarily found throughout various regions of the African continent. Its natural distribution spans across East Tropical Africa, where it can be located in Kenya, Tanzania, and Uganda. The plant also extends its reach into Northeast Tropical Africa, establishing a presence in countries such as Chad and Eritrea. This widespread geographic range highlights the adaptability of the species within diverse African landscapes. By observing these specific locations, researchers can better understand the environmental preferences of this unique succulent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Kalanchoe laciniata is a self-supporting herb that maintains a sturdy structure as it grows. This plant can reach a maximum height of approximately 1.83 meters. Its distinct growth form makes it a notable feature in its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Kalanchoe laciniata has been identified as a plant possessing both cytotoxic and mutagenic activities according to recent laboratory evaluations. Using Ames and MTT assays, researchers tested aqua-methanolic and n-hexane extracts to determine the plant's safety profile. The results indicated that the aqua-methanolic extract showed significant mutagenicity, particularly when exposed to the TA-102 strain of Salmonella typhimurium. Furthermore, both types of extracts demonstrated cytotoxic potential against the baby hamster kidney cell line. Because of these findings, further exploration is recommended to evaluate the safety of this medicinal plant in other species.
Compounds
Kalanchoe laciniata is a medicinal plant recognized for its complex phytochemical profile and potential therapeutic benefits. Preliminary screening has confirmed that this species contains essential bioactive compounds, including flavonoids and tannins. Furthermore, research has successfully detected the presence of the nitrile glycoside sarmentosin within the plant. These specific constituents contribute to the plant's ability to inhibit the nucleation, growth, and aggregation of calcium oxalate crystals. Such findings highlight the significant potential of Kalanchoe laciniata in the development of treatments for urolithiasis.
Conditions
Kalanchoe laciniata demonstrates significant therapeutic potential by treating CaOx urolithiasis through the inhibition of crystal nucleation, growth, and aggregation. In oncology, the plant's phytochemicals act as chemosensitizing agents that treat ABC transporter-mediated drug resistance in breast cancer. This effect is specifically evidenced by its ability to treat MDA-MB-231 breast cancer cells through dose-dependent cytotoxicity. Furthermore, the plant serves to treat multidrug resistance (MDR) by modulating key transporters like BCRP and MRP1. The bioactive extracts also exhibit a clear capacity to treat cytotoxicity in various cell line assays.
Preparations
Kalanchoe laciniata is prepared as aqua-methanolic and n-hexane extracts for scientific evaluation. These specific preparations were utilized to assess the genotoxic and cytotoxic potential of the plant. The aqua-methanolic extract demonstrated significant mutagenicity when tested against the TA-102 strain. Similarly, the n-hexane extract exhibited mutagenic properties across both tested strains. Both of these prepared extracts were ultimately found to possess notable mutagenic and cytotoxic potential.
Parts used
Kalanchoe laciniata leaves have been identified as a significant component in recent medicinal research regarding the treatment of urolithiasis. By utilizing aqueous, ethanol, and hexane extracts from these leaves, researchers investigated their ability to combat calcium oxalate crystal formation. The study demonstrated that these specific plant extracts can effectively inhibit the nucleation, growth, and aggregation of crystals within a synthetic urine system. Furthermore, phytochemical screening of the leaves revealed the presence of active compounds such as flavonoids, tannins, and polyphenols. These findings suggest that the leaves of Kalanchoe laciniata hold great potential for development into therapeutic inhibitors for kidney stone management.